Sterile compound cortex phellodendri freeze-dried stock solution, freeze-dried powder and preparation process thereof

By using a sterile compound Phellodendron amurense freeze-dried stock solution preparation process, the problems of low transportation safety and low freeze-drying efficiency of compound Phellodendron amurense liquid coating have been solved. This process ensures that the material basis remains unchanged, improves the safety and production efficiency of freeze-dried powder, and results in good product appearance and reconstitution effect.

CN118903283AActive Publication Date: 2024-11-08SHANDONG HANFANG PHARMA
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410507339.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-08
Filing Date
2024-04-25
Publication Date
2024-11-08
Estimated Expiration
2044-04-25

AI Technical Summary

Technical Problem

Existing compound berberine extract coatings are not safe enough during transportation, and the freeze-drying process is inefficient, with the material basis easily altered during processing, making it difficult to control product stability and quality.

Method used

The preparation process of aseptic compound Phellodendron bark freeze-dried stock solution involves multiple filtrations and specific freeze-drying conditions to reduce the volume of the freeze-dried stock solution. The freeze-dried powder is then produced by bottle freeze-drying, ensuring that the material basis remains unchanged and improving production efficiency.

Benefits of technology

It achieves the safety, effectiveness, and quality control of freeze-dried powder products, with a smooth appearance, good reconstitution effect, high packaging accuracy, and cost savings in production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903283A_ABST
    Figure CN118903283A_ABST
Patent Text Reader

Abstract

The invention provides a preparation process of a sterile compound cortex phellodendri freeze-dried stock solution, and relates to the technical field of deep processing of traditional Chinese medicines. The preparation process comprises the following steps: S1, taking compound cortex phellodendri liquid alcohol precipitation paste, adding purified water to prepare a certain volume, and refrigerating and standing to obtain a mixed solution; s2, taking supernate of the mixed solution in the step S1, and performing sterile filtration for at least i times through a filter membrane at the temperature of 28-45 DEG C to obtain the sterile compound cortex phellodendri freeze-dried stock solution. Wherein i is a natural number and traverses from 1 to n, and n is a natural number and is not less than 3. The aperture of the filter membrane for the (i + 1) th filtration is not greater than that of the filter membrane for the ith filtration; a certain volume in the step S1 is 580-1000 ml of the solution. According to the sterile compound cortex phellodendri freeze-dried stock solution prepared by the preparation method disclosed by the invention, the processing technology is improved, so that the volume of the sterile compound cortex phellodendri freeze-dried stock solution is reduced, and meanwhile, the material basis is not obviously changed.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application claims the priority of Chinese patent application No. 202310530146.6, filed on May 8, 2023. This application cites the entire text of the above Chinese patent application. Technical Field

[0002] The invention relates to the technical field of deep processing of traditional Chinese medicines, and in particular to a sterile compound phellodendron chinense freeze-dried stock solution, a compound phellodendron chinense freeze-dried powder and a preparation process of the sterile compound phellodendron chinense freeze-dried stock solution. Background Art

[0003] Compound Phellodendron liquid coating has the functions of clearing away heat, detoxifying, reducing swelling and removing rot, and is used for ulcers, wound infections, and patients with Yang syndrome. In clinical use, the treatment range ranges from skin damage to visceral cavity mucosal damage, and has high clinical value.

[0004] The Chinese invention patent with the patent publication number CN104398642 and the publication date of 2015.03.11 provides a method for preparing and testing the quality of compound phellodendron liquid. The quality testing method includes the identification of forsythia, phellodendron, honeysuckle and dandelion, the inspection of honeysuckle, and the determination of forsythiaside and berberine hydrochloride. The patent does not involve the investigation of the problem of changing the dosage form of compound phellodendron liquid coating. Summary of the invention

[0005] The inventors found that no preservatives or other auxiliary materials were used in the production process of the compound phellodendron liquid coating, and the finished product, as a liquid preparation, was not safe enough during transportation. Therefore, in order to ensure the transportation safety and stability of the product, a sterile freeze-dried powder preparation was developed. According to the "Classification and Application Materials Requirements for Registration of Traditional Chinese Medicine", the compound phellodendron freeze-dried powder is "2.2 Preparations that change the dosage form of marketed traditional Chinese medicines, that is, preparations that change the dosage form without changing the route of administration." It is necessary to ensure that the material basis does not change significantly (the change in the index component is within 5%). The safety, effectiveness, and quality controllability of the original product, the compound phellodendron liquid coating, have been verified during clinical use. By controlling the quality of the sterile compound phellodendron freeze-dried stock solution, the final freeze-dried powder product is controlled to ensure that the material basis has not changed significantly compared to the compound phellodendron liquid coating, thereby ensuring the safety, effectiveness, and quality controllability of the final compound phellodendron freeze-dried powder product.

[0006] The freeze-dried powder preparation is a sterile preparation, so it should be used all at once after opening. According to the recommended dosage of 10 to 20 ml in the instructions for the compound phellodendron liquid coating, combined with the convenience of clinical application, freeze-dried at a specification of 20 ml per bottle is selected. The inventor has found through research that according to the original process of the compound phellodendron liquid coating, the freeze-dried stock solution obtained after the alcohol sedimentation paste is configured to 1000 ml of refrigerated filtration with purified water can ensure that the material basis has not changed, but when freeze-dried in this case, the freeze-drying time is long, the energy consumption is high, and the later production efficiency is very low. In addition, under this configuration volume, only the material tray can be used for freeze-drying and then repackaging. In the process of crushing and repackaging, not only the cleanliness of the production environment must be controlled, but also the humidity must be controlled, otherwise it will cause repackaging and crushing difficulties, and the material will adhere during the crushing and repackaging process. In order to solve the above problems, the inventor has provided a sterile compound phellodendron freeze-dried stock solution after repeated experimental studies, which reduces the volume while ensuring that the material basis does not change significantly. At the same time, the freeze-drying method can be bottle freeze-drying. The freeze-dried powder product has good shape and reconstitution effect, high packaging accuracy, and is more conducive to improving production efficiency.

[0007] The first aspect of the present invention provides a preparation process of a sterile compound Phellodendron chinense freeze-dried stock solution, the preparation process comprising the following steps:

[0008] S1: Take the compound Phellodendron amurense liquid alcohol precipitate, add purified water to make up to a certain volume, and refrigerate and let stand to obtain a mixed solution.

[0009] S2: Take the supernatant of the mixed solution and filter it at least i times at a temperature of 28-45° C. through a filter membrane to obtain a sterile compound Phellodendron chinense freeze-dried stock solution.

[0010] Wherein, i is a natural number and ranges from 1 to n, n is a natural number and is not less than 3; the pore size of the filter membrane for the i+1th filtration is not greater than the pore size of the filter membrane for the ith filtration. The certain volume in step S1 is configured to 580-1000 ml.

[0011] The second aspect of the present invention provides a sterile compound Phellodendron chinense freeze-dried stock solution, which is prepared by the above-mentioned preparation process.

[0012] The third aspect of the present invention provides a compound Phellodendron chinense freeze-dried powder, which is prepared by using the above-mentioned sterile compound Phellodendron chinense freeze-dried stock solution. The preparation method comprises the following steps:

[0013] The sterile compound Phellodendron chinense freeze-dried stock solution is pre-frozen at a pressure of 0 to 3Pa and a temperature of -47°C to -43°C; then sublimated once at a pressure of 8 to 12Pa and a temperature of -12°C to -8°C; finally, analytical drying is performed at a pressure of 28 to 32Pa and a temperature of 38 to 42°C to obtain the compound Phellodendron chinense freeze-dried powder.

[0014] Compared with the prior art, the present invention achieves at least one of the following beneficial effects:

[0015] (1) The sterile compound Phellodendron chinense freeze-dried stock solution prepared by the present invention reduces the volume of the sterile compound Phellodendron chinense freeze-dried stock solution by improving the processing technology while ensuring that the material basis does not change significantly.

[0016] (2) The sterile compound Phellodendron chinense freeze-dried stock solution prepared by the present invention can be made into freeze-dried powder by bottle freeze-drying, which has high packaging accuracy, improves production efficiency and saves production costs.

[0017] (3) The present invention controls the material basis of the sterile compound Phellodendron chinense freeze-dried stock solution to control the final freeze-dried powder product, ensuring that the material basis of the freeze-dried powder product does not change significantly compared to the compound Phellodendron chinense liquid coating, thereby ensuring the safety, effectiveness and quality controllability of the final compound Phellodendron chinense freeze-dried powder product.

[0018] (4) The compound Phellodendron chinense freeze-dried powder prepared from the sterile compound Phellodendron chinense freeze-dried stock solution of the present invention has a smooth appearance, uniform color, no obvious stratification and color difference, and good re-dissolution effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] The drawings described herein are used to provide a further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0020] Figure 1 It shows the product state diagram of freeze-dried compound Phellodendron chinense freeze-dried stock liquid in comparative example 3 of the present invention, which is freeze-dried to prepare freeze-dried compound Phellodendron chinense powder;

[0021] Figure 2 The product state diagram of the freeze-dried compound cortex phellodendri powder prepared by freeze-drying the sterile compound cortex phellodendri stock solution bottle in Example 1 of the present invention is shown;

[0022] Figure 3 The product state diagram of the freeze-dried powder of compound Phellodendron chinense obtained by freeze-drying the sterile freeze-dried stock solution of compound Phellodendron chinense in comparative example 3 of the present invention is shown. DETAILED DESCRIPTION

[0023] In order to more clearly illustrate the overall concept of the present invention, a detailed description is given below in an exemplary manner in conjunction with the accompanying drawings.

[0024] In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention may also be implemented in other ways different from those described herein. Therefore, the scope of protection of the present invention is not limited by the specific embodiments disclosed below. In addition, any methods and materials similar or equivalent to those described herein may be applied to the present invention. The preferred implementation methods and materials described in this patent are for demonstration purposes only.

[0025] In an exemplary embodiment of the present invention, the preparation process of the sterile compound Phellodendron chinense freeze-dried stock solution comprises the following steps:

[0026] S1: Take the compound Huangbai liquid alcohol sediment, add purified water to a certain volume, refrigerate and let stand to obtain a mixed solution. The certain volume is 580-1000ml. Preferably, the certain volume is 600-800ml. More preferably, the certain volume is 600ml.

[0027] Optionally, the preparation method of the compound phellodendron liquid alcohol precipitate comprises the following steps: weigh the five Chinese medicinal materials of the compound phellodendron liquid according to the weight components. Among them, 80±10 weight parts of forsythia, 40±5 weight parts of phellodendron, 40±5 weight parts of honeysuckle, 40±5 weight parts of dandelion, and 2.4±0.3 weight parts of centipede. Add water and decoct for extraction three times; combine the decoctions, filter, and concentrate the filtrate to a clear paste (50°C) with a relative density of 1.10 to 1.15; then add ethanol to the clear paste to make the ethanol content reach 60 to 70%, let it stand, filter, and concentrate the filtrate under reduced pressure to obtain the compound phellodendron liquid alcohol precipitate.

[0028] Specifically, for example, in one weight component of the compound phellodendron liquid alcohol precipitate, there are 80±10g of Forsythia suspensa, 40±5g of phellodendron, 40±5g of honeysuckle, 40±5g of dandelion, and 2.4±0.3g of centipede, in step S1, take one weight component of the compound phellodendron liquid alcohol precipitate and add purified water to prepare it to 580-1000ml.

[0029] In the 20 weight components of the compound phellodendron liquid alcohol sediment, 1600±200g of forsythia, 800±100g of phellodendron, 800±100g of honeysuckle, 800±100g of dandelion, and 48±6g of centipede, 20 weight components of the compound phellodendron liquid alcohol sediment in step S1 are added with purified water to be configured to 11600-20000ml. The ratio of the weight components of the compound phellodendron liquid alcohol sediment to a certain volume is 1 weight component: 580-1000ml.

[0030] Optionally, the purified water is water for injection, which refers to water obtained by distilling purified water. The inspection requirements for microbial limits in water for injection are higher than those for purified water, and there are inspection requirements for bacterial endotoxins, which is more suitable for use in sterile products.

[0031] S2: taking the supernatant of the mixed solution in step S1 and filtering it at least i times through a filter membrane at a temperature of 28-45° C. to obtain a sterile compound Phellodendron chinense freeze-dried stock solution.

[0032] Wherein, i is a natural number and ranges from 1 to n, n is a natural number and is not less than 3; the pore size of the filter membrane for the i+1th filtration is not greater than the pore size of the filter membrane for the i-th filtration.

[0033] Optionally, the supernatant in step S2 is kept at a temperature of 28-45°C for more than 3 hours. Preferably, the temperature in step S2 is 30-40°C.

[0034] Optionally, i can be 3, and sterile filtration can be performed three times to obtain a sterile compound phellodendron freeze-dried stock solution. For example, the pore size of the filter membrane for the first filtration is not greater than 0.5 μm, the pore size of the filter membrane for the second filtration is not greater than 0.3 μm, and the pore size of the filter membrane for the third filtration is not greater than 0.3 μm. For example, the pore size of the filter membrane for the first filtration is 0.45 μm, the pore size of the filter membrane for the second filtration is 0.22 μm, and the pore size of the filter membrane for the third filtration is 0.22 μm.

[0035] In an exemplary embodiment of the present invention, the compound Phellodendron chinense freeze-dried powder is prepared by using the above-mentioned sterile compound Phellodendron chinense freeze-dried stock solution, and the preparation method comprises the following steps:

[0036] The sterile compound phellodendron freeze-dried stock solution is pre-frozen at a pressure of 0 to 3Pa and a temperature of -47°C to -43°C; then it is sublimated once at a pressure of 8 to 12Pa and a temperature of -12°C to -8°C; finally, it is dried by analytical analysis at a pressure of 28 to 32Pa and a temperature of 38 to 42°C to obtain the compound phellodendron freeze-dried powder. Compared with the freeze-dried in a tray, the sterile compound phellodendron freeze-dried stock solution prepared by the present invention can be directly obtained by freeze-drying in a bottle without the need for crushing and sieving. The problem of crushing and packaging to control the production environment in the later stage is avoided.

[0037] Example 1

[0038] (1) Preparation of compound Phellodendron chinense liquid alcohol precipitate

[0039] Take five medicinal materials of compound phellodendron liquid, including 80g of forsythia, 40g of phellodendron, 40g of honeysuckle, 40g of dandelion and 2.4g of centipede. Add water and boil for three times, the first time for 1 hour, the second time for 45 minutes and the third time for 30 minutes, combine the decoctions, filter, concentrate the filtrate to a clear paste with a relative density of 1.10-1.15, add ethanol to make the alcohol content reach 70%, let it stand for 24 hours, filter, and concentrate the filtrate under reduced pressure to no alcohol taste to obtain compound phellodendron liquid alcohol precipitate.

[0040] (2) Take the above compound Phellodendron amurense liquid alcohol precipitate, add purified water to make up to 600 ml, stir for 15 minutes, refrigerate and let stand for 24 hours, take the supernatant and sterile filter it at 30°C (the first time with 0.45 μm filter membrane, the second and third times with 0.22 μm filter membrane), and obtain a sterile compound Phellodendron amurense freeze-dried stock solution.

[0041] Example 2

[0042] On the basis of Example 1, the above-mentioned compound Phellodendron amurense liquid alcohol precipitate was taken, purified water was added to 1000 ml, stirred for 15 minutes, refrigerated and allowed to stand for 24 hours, the supernatant was taken and kept at 40°C for 3 hours and then sterile filtered (first time with 0.45 μm filter membrane, second and third times with 0.22 μm filter membrane) to obtain a sterile compound Phellodendron amurense freeze-dried stock solution.

[0043] Example 3

[0044] On the basis of Example 1, the above-mentioned compound Phellodendron amurense liquid alcohol sediment was taken, purified water was added to 800 ml, stirred for 15 minutes, refrigerated and allowed to stand for 24 hours, and the supernatant was sterile filtered at 30°C (first time with 0.45 μm filter membrane, second and third times with 0.22 μm filter membrane) to obtain a sterile compound Phellodendron amurense freeze-dried stock solution.

[0045] Example 4

[0046] (1) Preparation of compound Phellodendron chinense liquid alcohol precipitate

[0047] Take five medicinal materials of compound phellodendron liquid, including 1600g of forsythia, 800g of phellodendron, 800g of honeysuckle, 800g of dandelion and 48g of centipede. Add water and boil for three times, the first time for 1 hour, the second time for 45 minutes and the third time for 30 minutes, combine the decoction, filter, concentrate the filtrate to a clear paste with a relative density of 1.10-1.15, add ethanol to make the alcohol content reach 70%, let it stand for 24 hours, filter, and concentrate the filtrate under reduced pressure to no alcohol taste to obtain compound phellodendron liquid alcohol precipitate paste.

[0048] (2) Take the above compound Phellodendron amurense liquid alcohol precipitate, add water for injection to make up to 12000 ml, stir, let stand, refrigerate for 24 hours, take the supernatant and sterile filter it at 40°C (the first time through 0.45 μm filter membrane, the second and third times through 0.22 μm filter membrane), and obtain a sterile compound Phellodendron amurense freeze-dried stock solution.

[0049] Comparative Example 1

[0050] On the basis of Example 1, the compound Phellodendron amurense liquid alcohol sediment was taken, purified water was added to 200 ml, stirred for 15 minutes, refrigerated and allowed to stand for 24 hours, and the supernatant was filtered at 50°C using sterile filtration (the first time with 0.45 μm filter membrane, the second and third times with 0.22 μm filter membrane) to obtain a sterile compound Phellodendron amurense freeze-dried stock solution.

[0051] Comparative Example 2

[0052] On the basis of Example 1, the compound Phellodendron amurense liquid alcohol precipitate was taken, purified water was added to 400 ml, stirred for 15 minutes, refrigerated and allowed to stand for 24 hours, the supernatant was taken, and filtered at refrigerated temperature (2-10°C) using sterile filtration (first 0.45 μm filter membrane, second and third 0.22 μm filter membrane) to obtain a sterile compound Phellodendron amurense freeze-dried stock solution.

[0053] Comparative Example 3

[0054] On the basis of Example 1, take the compound Phellodendron amurense liquid alcohol precipitate, add purified water to 1000 ml, stir for 15 minutes, refrigerate and let stand for 24 hours, take the supernatant, filter with filter paper at refrigerated temperature (2-10°C) to obtain the compound Phellodendron amurense freeze-dried stock solution.

[0055] According to the determination method of forsythin, berberine hydrochloride and total solids under the compound phellodendron liquid coating in the Chinese Pharmacopoeia (2020 edition), the following tests were performed. The freeze-dried stock solutions prepared in the above Examples 1-4 and Comparative Examples 1-3 were subjected to two parallel tests respectively, and the processing conditions and material basis components of the freeze-dried stock solutions are shown in Table 1.

[0056] Table 1 Processing conditions and material base components

[0057]

[0058]

[0059] In order to verify whether the material basis of the prepared sterile compound Phellodendron chinense freeze-dried stock solution is changed compared with the compound Phellodendron chinense liquid coating (Comparative Example 3 in Table 2), the configuration volume of the above-mentioned embodiments and comparative examples is converted to 1000 ml, and the average content of each index component when the converted configuration volume is 1000 ml is calculated, and the deviation value of the content of each index component is calculated. The results are shown in Reference Table 2.

[0060]

[0061] Table 2

[0062]

[0063] As shown in Table 2, it can be seen from Examples 1-4 that the deviation values ​​of the index components (forsythin, berberine hydrochloride, total solids) are within 5%, proving that the material basis of the sterile compound Phellodendron chinense freeze-dried stock solution obtained by the preparation process of the present invention has not changed significantly.

[0064] Comparative Example 3 is to directly use the compound phellodendron liquid alcohol precipitate to 1000ml, and filter it with filter paper at a refrigerated temperature of 2-10°C. This is a compound phellodendron liquid coating process, which can ensure that the material basis does not change, but in the later stage, it can only be freeze-dried by means of a tray. Figure 1 As shown, Figure 1 This is a product state diagram of the freeze-dried compound phellodendron chinense freeze-dried stock liquid in comparative example 3 of the present invention, and the sample loading height is 10 mm. In the later stage of crushing and subpackaging, not only the cleanliness of the production environment but also the humidity must be controlled, which makes the later subpackaging and crushing more difficult.

[0065] Compared with Example 1, the main difference of Comparative Example 1 is that when the configuration volume is too low and the temperature is increased for sterile filtration, the deviation values ​​of the index components (forsythiaside, berberine hydrochloride, total solids) all exceed 5%, and the material basis components are changed.

[0066] The main difference between Comparative Example 2 and Comparative Example 3 is that when the configuration volume is too low, sterile filtration is performed at refrigerated temperature, the berberine hydrochloride deviation value exceeds 5%, the total solid deviation value exceeds 5%, and the material basis composition changes.

[0067] Compared with Comparative Example 3, the main difference between Example 2 and Comparative Example 3 is that when the supernatant is sterile filtered by heating, the pass rate of forsythin is slightly decreased, and the pass rate of berberine hydrochloride is slightly increased. The present invention controls the configuration volume and the insulation temperature so that the basic components of the prepared sterile compound Phellodendron chinense freeze-dried stock solution do not change significantly.

[0068] Under the condition that the material basis is not significantly changed, the sterile compound phellodendron freeze-dried stock solution prepared in Example 1 is divided into 12 ml portions and the sample height is 15 mm for bottle freeze-drying. It is first pre-frozen at a pressure of 2 Pa and a temperature of -45°C; then sublimated once at a pressure of 10 Pa and a temperature of -10°C; and finally, dried by analytical drying at a pressure of 30 Pa and a temperature of 40°C to obtain the compound phellodendron freeze-dried powder. The compound phellodendron freeze-dried powder obtained by bottle freeze-drying is referred to Figure 2 Reference Figure 2 It can be seen that the compound Phellodendron chinense freeze-dried powder prepared by the present invention has good product morphology and reconstitution effect and high packaging accuracy.

[0069] The freeze-dried stock solution of the compound phellodendron prepared in comparative example 3 was divided into 20 ml portions by the freeze-drying method of example 1, and the sample filling height was 23 mm for bottle freeze-drying. The freeze-dried powder of the compound phellodendron prepared in comparative example 3 was prepared as reference Figure 3 Reference Figure 3It can be seen that the compound phellodendron liquid alcohol precipitate is configured to 1000ml and filtered with filter paper at a refrigerated temperature of 2-10°C. This is the process of compound phellodendron liquid coating, which can ensure that the material basis does not change. However, during the subsequent bottle freeze-drying, the compound phellodendron freeze-dried powder cannot be prepared. Figure 3 It can be seen that when freeze-drying the bottle, the middle of the freeze-dried sample appears to be sandwich-like melting, or the whole sample collapses and shrinks.

[0070] The above description is only an embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent substitution, improvement, etc. made within the spirit and principle of the present invention should be included in the scope of the claims of the present invention.

Claims

1. A preparation process of a sterile compound Phellodendron chinense freeze-dried stock solution, It is characterized in that The preparation process comprises the following steps: S1: Take the compound Huangbai liquid alcohol sediment, add purified water to a certain volume, and refrigerate and stand to obtain a mixed solution; S2: taking the supernatant of the mixed solution in step S1 and filtering it at least i times through a filter membrane at a temperature of 28 to 45° C. to obtain a sterile compound Phellodendron chinense freeze-dried stock solution; Wherein, i is a natural number and ranges from 1 to n, n is a natural number and is not less than 3; the pore size of the filter membrane for the i+1th filtration is not greater than the pore size of the filter membrane for the i-th filtration; In the step S1, the certain volume is configured to be 580-1000 ml.

2. The preparation process according to claim 1, It is characterized in that In the step S1, the certain volume is configured to 600-800 ml.

3. The preparation process according to claim 1, It is characterized in that In the step S1, the certain volume is configured to 600 ml.

4. The preparation process according to claim 1, It is characterized in that The temperature of step S2 is 30-40°C.

5. The preparation process according to claim 1, It is characterized in that The purified water in step S1 is water for injection.

6. The preparation process according to claim 1, It is characterized in that The i is 3, the pore size of the filter membrane for the first filtration is not greater than 0.5 μm, the pore size of the filter membrane for the second filtration is not greater than 0.3 μm, and the pore size of the filter membrane for the third filtration is not greater than 0.3 μm.

7. The preparation process according to claim 6, It is characterized in that The pore size of the filter membrane for the first filtration is 0.45 μm, the pore size of the filter membrane for the second filtration is 0.22 μm, and the pore size of the filter membrane for the third filtration is 0.22 μm.

8. The preparation process according to claim 1, It is characterized in that The preparation method of the compound Phellodendron chinense liquid alcohol sediment comprises the following steps: According to weight, weigh 80±10 parts of Forsythia suspensa, 40±5 parts of Phellodendron chinense, 40±5 parts of Honeysuckle, 40±5 parts of Taraxacum herba, and 2.4±0.3 parts of Scolopendra subspinipes; add water and decoct for extraction three times; combine the decoctions, filter, and concentrate the filtrate to a clear paste with a relative density of 1.10-1.15; then add ethanol to the clear paste to make the ethanol content reach 60-70%, let it stand, filter, and concentrate the filtrate under reduced pressure to obtain the compound Phellodendron chinense liquid-alcohol precipitate.

9. A sterile compound Phellodendron chinense freeze-dried stock solution, It is characterized in that The sterile compound Phellodendron chinense freeze-dried stock solution is prepared by the preparation process described in any one of claims 1 to 8.

10. A compound Phellodendron chinense freeze-dried powder, It is characterized in that The compound Phellodendron chinense freeze-dried powder is prepared by using the sterile compound Phellodendron chinense freeze-dried stock solution according to claim 9, comprising the following steps: The sterile compound Phellodendron chinense freeze-dried stock solution is pre-frozen at a pressure of 0 to 3Pa and a temperature of -47°C to -43°C; then sublimated once at a pressure of 8 to 12Pa and a temperature of -12°C to -8°C; finally, analytical drying is performed at a pressure of 28 to 32Pa and a temperature of 38 to 42°C to obtain the compound Phellodendron chinense freeze-dried powder.

Citation Information

Patent Citations

  • Preparation and quality detection method of compound prescription cortex phellodendri chinensis fluid

    CN104398642A

  • Preparation method and application of fufang huangbaiye tuji

    CN106177082A

  • Preparation process and application of compound cortex phellodendri liquid coating agent

    CN113350411A

  • Rehabilitation lyophilized powder injection and its preparation method

    CN1762416A